(Q53427766)

14 May 2018

title

Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease. (English)

1 reference

14 May 2018

P Wolkow

5

0 references

Agnieszka Słowik

7

object named as

A Slowik

1 reference

Aleksandra Klimkowicz-Mrowiec

14 May 2018

1

object named as

A Klimkowicz-Mrowiec

1 reference

14 May 2018

Andrzej Szczudlik

6

object named as

A Szczudlik

1 reference

14 May 2018

author name string

M Marona

2

1 reference

14 May 2018

K Spisak

3

1 reference

14 May 2018

J Jagiella

4

1 reference

14 May 2018

publication date

5 August 2011

1 reference

14 May 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

14 May 2018

volume

32

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

26-31

1 reference

14 May 2018

Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis

cites work

1 reference

Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.

21 January 2018

1 reference

Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity

21 January 2018

1 reference

Pharmacogenetics of paraoxonases: a brief review

21 January 2018

1 reference

Polymorphisms in the human paraoxonase (PON1) promoter

21 January 2018

1 reference

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

21 January 2018

1 reference

Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.

21 January 2018

1 reference

Responsiveness to cholinesterase inhibitors in Alzheimer's disease: a possible role for the 192 Q/R polymorphism of the PON-1 gene.

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

21 January 2018

1 reference

Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

21 January 2018

1 reference

Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease

21 January 2018

1 reference

Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders

21 January 2018

1 reference

A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease

21 January 2018

1 reference

Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease

21 January 2018

1 reference

Cognitive predictors of donepezil therapy response in Alzheimer disease

21 January 2018

1 reference

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model

21 January 2018

1 reference

Pharmacogenomics and therapeutic prospects in dementia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000330343

1 reference

14 May 2018

1 reference

14 May 2018